EUROFINS SCIENT Total Long-Term Assets 2018-2024 | ERFSF
EUROFINS SCIENT total long-term assets from 2018 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
- EUROFINS SCIENT total long-term assets for the quarter ending December 31, 2024 were $12.240B, a 12.4% increase year-over-year.
- EUROFINS SCIENT total long-term assets for 2024 were $9.129B, a 7.83% increase from 2023.
- EUROFINS SCIENT total long-term assets for 2023 were $8.466B, a 3.41% increase from 2022.
- EUROFINS SCIENT total long-term assets for 2022 were $8.187B, a 1.33% decline from 2021.
| EUROFINS SCIENT Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $9,129 |
| 2023 | $8,466 |
| 2022 | $8,187 |
| 2021 | $8,297 |
| 2020 | $6,919 |
| 2019 | $6,965 |
| 2018 | $6,496 |
| 2017 | $4,528 |
| 2016 | $0 |
| 2015 | $0 |
| EUROFINS SCIENT Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $12,240 |
| 2024-06-30 | $8,813 |
| 2023-06-30 | $6,025 |
| 2022-12-31 | $10,893 |
| 2021-12-31 | $10,890 |
| 2021-06-30 | $5,519 |
| 2020-12-31 | $8,941 |
| 2020-06-30 | $5,048 |
| 2019-12-31 | $8,733 |
| 2019-06-30 | $5,205 |
| 2018-12-31 | $7,834 |
| 2018-06-30 | $4,185 |
| 2017-12-31 | $5,630 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.026B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.009B | 27.20 |
| Elevance Health (ELV) | United States | $86.741B | 11.19 |
| CVS Health (CVS) | United States | $81.290B | 10.10 |
| Cencora (COR) | United States | $55.092B | 19.17 |
| DiDi Global (DIDIY) | China | $23.485B | 35.64 |
| Natera (NTRA) | United States | $22.560B | 0.00 |
| BioMerieux (BMXMF) | France | $16.856B | 0.00 |
| Solventum (SOLV) | United States | $13.071B | 13.84 |
| ICON (ICLR) | Ireland | $11.688B | 10.87 |
| Revvity (RVTY) | United States | $11.345B | 19.52 |
| CochLear (CHEOY) | Australia | $11.134B | 0.00 |
| Doximity (DOCS) | United States | $10.995B | 50.90 |
| Viatris (VTRS) | United States | $10.610B | 3.65 |
| Avantor (AVTR) | United States | $9.329B | 13.55 |
| HealthEquity (HQY) | United States | $9.272B | 40.61 |
| Medpace Holdings (MEDP) | United States | $8.792B | 23.35 |
| Sonic Healthcare (SKHHY) | Australia | $8.450B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.416B | 14.53 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.450B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $3.875B | 35.87 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Surgery Partners (SGRY) | United States | $2.989B | 38.87 |
| Alignment Healthcare (ALHC) | United States | $2.898B | 0.00 |
| Concentras Parent (CON) | United States | $2.816B | 16.27 |
| Organon (OGN) | United States | $2.610B | 2.77 |
| GeneDx Holdings (WGS) | United States | $1.983B | 76.39 |
| Progyny (PGNY) | United States | $1.923B | 42.32 |
| Ardent Health Partners (ARDT) | United States | $1.920B | 8.18 |
| Premier (PINC) | United States | $1.884B | 14.30 |
| PACS (PACS) | United States | $1.629B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.622B | 32.43 |
| Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.213B | 9.23 |
| Establishment Labs Holdings (ESTA) | $1.124B | 0.00 | |
| CareDx (CDNA) | United States | $1.105B | 17.26 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.944B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.843B | 7.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.752B | 0.00 |
| Nutex Health (NUTX) | United States | $0.651B | 9.85 |
| Embecta (EMBC) | United States | $0.592B | 3.99 |
| LifeMD (LFMD) | United States | $0.553B | 0.00 |
| Enhabit (EHAB) | United States | $0.543B | 44.67 |
| InnovAge Holding (INNV) | United States | $0.514B | 0.00 |
| SBC Medicals (SBC) | United States | $0.495B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.445B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.258B | 0.00 |
| Oncology Institute (TOI) | United States | $0.237B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.104B | 0.00 |
| So-Young (SY) | China | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.079B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.075B | 0.00 |
| KindlyMD (NAKA) | United States | $0.070B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.056B | 0.00 |
| Biodesix (BDSX) | United States | $0.048B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |